( Bloomberg:GNP@IN, RICS:GLEN, ISIN:INE935A01035 )

News from Glenmark Pharmaceuticals Ltd A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Sep 03, 2015, 08:36 ET Glenmark's Novel Monoclonal Antibody GBR 830 to Enter Phase 2 Clinical Studies in Atopic Dermatitis and Celiac Disease in US and Europe

- GBR 830 Completes Clinical Phase 1 Successfully in The Netherlands - The Antibody has Been Well Tolerated With a Favourable Pharmacokinetic...


Nov 05, 2014, 01:05 ET Glenmark Generics Receives Final ANDA Approval for Omeprazole DR Capsules

Glenmark Generics Inc. USA, the subsidiary of Glenmark Generics Limited, has been granted final approval for its abbreviated new drug application...


Oct 30, 2014, 13:25 ET Glenmark's Consolidated Revenue Increases by 14.85% to Rs. 16,807.08 Mn in Q2 FY 14-15

Net Profit for the second quarter increases by 7% to Rs 1650.78 Mn   Business Highlights   - India Business grew by 14.48 % to...


Oct 28, 2014, 05:19 ET Glenmark Facilitates 'PharmaEDGE'- A Unique Continuing Professional Development (CPD) Program for Pharmacists of MENA Countries

PharmaEDGE, a unique Continuing Professional Development (CPD) Program for pharmacists of Middle East and North African (MENA) countries was...


Sep 25, 2014, 03:25 ET Glenmark Conferred Civic Award 2013-14 for Social Development by the Bombay Chamber of Commerce and Industry

Presented the Prestigious Distinction for Exemplary Initiatives in the Area of Corporate Social Responsibility   Glenmark Pharmaceuticals...


Aug 20, 2014, 06:05 ET Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody

Glenmark Pharmaceuticals S.A. (GPSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Limited India (GPL), announces the discovery and...


Jul 17, 2014, 07:11 ET Glenmark Pharmaceuticals to Set up a New Manufacturing Facility in the US

- The Facility Will be Situated in Monroe, North Carolina, USA - It Will Manufacture Oral Solids, Injectables and Topicals Over a Five Year...


Jul 03, 2014, 09:04 ET Glenmark's Novel Monoclonal Antibody GBR 830 for Treatment of Autoimmune Diseases Entering Human Trials

  - GBR 830 is an antagonistic monoclonal antibody with first in class potential for the treatment of autoimmune diseases targeting...


Jul 02, 2014, 09:50 ET Doctors' Role Commemorated on Doctor's Day by Creating World's Largest Pet Bottle Mosaic in the Shape of a Smile at JJ Hospital, Mumbai

~All the expectorant pet bottles used in creating this smiley are to be donated to 32 Government Hospitals across the country to provide relief...


Dec 23, 2013, 08:03 ET mMitra, a Free Voice Messaging Health Advisory Service Launched for Pregnant Women & Mothers at Sion Hospital, Mumbai

First of its kind public-private partnership between an NGO, Corporate and Government Institution, coming together for a social cause mMitra, a...


Dec 02, 2013, 02:55 ET Glenmark Announces Appointment of Mr. Philip Andrew Gioia (Phil) as President North America and Global API Business

Glenmark Pharmaceuticals announces the appointment of Mr. Philip Andrew Gioia (Phil) as President North America and Global API business. Phil has...


Oct 31, 2013, 10:08 ET Glenmark's Consolidated Revenue Increases by 16.56% to Rs. 14630.06 Mn for Q2 FY 13-14

Net Profit for the second quarter was Rs 1542.97 Mn as compared to Rs. 1567.52 mn for the previous corresponding...


Oct 29, 2013, 05:17 ET 'EDGE' - An Internationally Accredited Innovative Dermatology CME Program Held in United Arab Emirates and the Sultanate of Oman on 11th - 12th October, 2013

'EDGE (Excellence in Dermatology a Global InitiativE)' an internationally accredited continuing medical education (CME) program for...


Jul 24, 2013, 08:00 ET Glenmark Pharmaceuticals annonce le lancement de son programme RSE pour la Santé infantile au Kenya

Glenmark, la principale compagnie pharmaceutique internationale intégrée et axée sur la recherche, a annoncé le lancement de son Programme de...


Jul 23, 2013, 10:24 ET Glenmark Pharmaceuticals Announces Launch of its Child Health CSR Programme in Kenya

Glenmark, the leading research-driven, global, integrated pharmaceutical company has announced the launch of its Child Health Corporate...


Jun 26, 2013, 03:03 ET Glenmark Foundation' Announces Positive Impact of its Child Health Programme in Madhya Pradesh Focused on the Marginalized Korku Tribe

Shri Mahendra Hardia, Honorable Health Minister, Madhya Pradesh graces the occasion along with other dignitaries from the State...


Feb 04, 2013, 06:08 ET Glenmark Announces a New Discovery and the Initiation of IND Enabling Studies of a Novel Monoclonal Antibody Targeting OX40

- GBR 830 is the first antagonistic antibody targeting OX40 and is a potential Global First-in-class molecule - OX40, also known as...


Feb 04, 2013, 06:08 ET Glenmark Announces a New Discovery and the Initiation of IND Enabling Studies of a Novel Monoclonal Antibody Targeting OX40

- GBR 830 is the first antagonistic antibody targeting OX40 and is a potential Global First-in-class molecule - OX40, also known as...


Feb 04, 2013, 05:09 ET Glenmark Announces a New Discovery and the Initiation of IND Enabling Studies of a Novel Monoclonal Antibody Targeting OX40

- GBR 830 is the First Antagonistic Antibody Targeting OX40 and is a Potential Global First-in-class Molecule - OX40, Also Known as CD134, Plays...


Jan 29, 2013, 23:43 ET Glenmark's Consolidated Revenue Increases by 33.96% to Rs. 13812.59 Million for Q3 FY 12-13

Net Profit for the Third Quarter was Rs. 2129.17 Mn as Compared to Rs. 448.24 Mn for the Previous Corresponding Quarter Highlights: Q3-FY13 -...


Jan 02, 2013, 04:43 ET USFDA Approves Crofelemer 125 mg Delayed-release Tablets for the Symptomatic Relief of Diarrhea in Patients With HIV/AIDS on Anti-Retroviral Therapy (ART)

This Will be the First NCE (New Chemical Entity) Launch by an Indian Company Across Multiple Geographies Glenmark Pharmaceuticals Limited...


Dec 11, 2012, 02:00 ET Vorsitzender & Managing Director von Glenmark Pharma - Herr Glenn Saldanha - erhielt Preis des Schweizer Botschafters für außergewöhnliche Innovation

~Die außergewöhnliche Arbeit der Wissenschaftler von Glenmarks neuen F&E-Zentrum für Biologika in Neuchâtel (Schweiz)...


Dec 11, 2012, 02:00 ET M. Glenn Saldanha, président du conseil d'administration et PDG de Glenmark Pharma reçoit le Prix de l'ambassadeur pour innovation exceptionnelle

~ Le travail exceptionnel accompli par les chercheurs de Glenmark dans son nouveau centre de recherche et développement biologique, à...


Nov 30, 2012, 04:25 ET Mr. Glenn Saldanha Honoured With 'Swiss Ambassador's Award for Exceptional Innovation'

Mr. Glenn Saldanha Becomes the Third Recipient of This Prestigious Award After Mr. Ratan Tata, Chairman, Tata Group in 2011 and Mr. Yash Chopra in...


Oct 30, 2012, 07:02 ET Glenmark's Consolidated Revenue Increases by 18.9% to Rs. 12551.9 Mn for Q2 FY'12-13

Net Profit for the Second Quarter was Rs 1567.52 Mn as Compared to Rs. 782.75 Mn for the Previous Quarter, Recording Growth of 100.2% Glenmark...